Insider filing · BIIB
Rachid Izzar
Head of Global Product Strat.
profile →
Biogen Inc.
BIIB · Healthcare · 16 filings in 24 months
ticker →
Rachid Izzar sold $300K of Biogen (BIIB)
Executed Jul 8 2025, disclosed Jul 16 2025, 8 days later, against a two-business-day limit.
Value, as filed
$300K
2,223 sh × $135.00
Executed
Jul 8 2025
the trade date, as filed
Disclosed
Jul 16 2025
8 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RIRachid Izzar (Head of Global Product Strat.) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Biogen Inc. (BIIB). The largest single filing was $300K of BIIB (2,223 sh × $135.00, as filed), executed Jul 8 2025.
The name
BIIBHealthcare · Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→